Cargando…

Remdesivir-associated bradycardia might be a sign of good prognosis in COVID-19 patients

Detalles Bibliográficos
Autores principales:	Lucijanic, Marko, Bistrovic, Petra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733221/ https://www.ncbi.nlm.nih.gov/pubmed/34999175 http://dx.doi.org/10.1016/j.cmi.2021.12.017

Ejemplares similares

Remdesivir use in COVID-19 patients might predispose bacteremia, matched case-control analysis
por: Lucijanic, Marko, et al.
Publicado: (2022)

Remdesivir use in severe and critical COVID-19 patients might be associated with lower incidence of arterial thrombotic events
por: Lucijanic, Marko, et al.
Publicado: (2023)

P1563: REMDESIVIR USE IN SEVERE AND CRITICAL COVID-19 PATIENTS MIGHT BE ASSOCIATED WITH LOWER INCIDENCE OF ARTERIAL THROMBOTIC EVENTS
por: Lucijanic, Marko, et al.
Publicado: (2023)

Atrial fibrillation in COVID-19 patients receiving remdesivir, matched case-control analysis
por: Bistrovic, Petra, et al.
Publicado: (2022)

Remdesivir treatment and transient bradycardia in patients with coronavirus diseases 2019 (COVID-19)
por: Pallotto, Carlo, et al.
Publicado: (2021)

Bradycardia due to remdesivir: Report of two cases()
por: Cebrián Lara, Laura, et al.
Publicado: (2022)

Remdesivir-associated bradycardia
por: Ching, Patrick R, et al.
Publicado: (2021)

Remdesivir for COVID-19 pneumonia: still undecided, but it might all be about adequate timing
por: Trkulja, Vladimir
Publicado: (2021)

Remdesivir induced bradycardia and QT prolongation: A rare side effect of a ubiquitous drug of the COVID -19 era
por: Singla, Karan, et al.
Publicado: (2022)

Cough cardiopulmonary resuscitation for bradycardia management: good or bad?
por: Gupta, Nishkarsh, et al.
Publicado: (2019)

Higher ferritin levels in COVID-19 patients are associated with hyperinflammation, worse prognosis, and more bacterial infections without pronounced features of hemophagocytosis
por: Lucijanic, Marko, et al.
Publicado: (2022)

Clinical implication of COVID‐19 associated bradycardia
por: Miyauchi, Masaya, et al.
Publicado: (2021)

Relative bradycardia in patients with COVID-19
por: Capoferri, Gioele, et al.
Publicado: (2021)

REMDESIVIR-ASSOCIATED ASYMPTOMATIC BRADYCARDIA IN AN ICU PATIENT ON DEXAMETHASONE FOR COVID-19
por: HAIDER, MOBEEN, et al.
Publicado: (2022)

REMDESIVIR-INDUCED EXTREME SINUS BRADYCARDIA IN COVID-19
por: Hamilton, Steven A., et al.
Publicado: (2022)

Remdesivir-Induced Marked Sinus Bradycardia in COVID-19
por: Ahmed, Taimoor, et al.
Publicado: (2022)

Remdesivir-Induced Extreme Sinus Bradycardia in COVID-19
por: Wasef, Natale, et al.
Publicado: (2022)

Remdesivir and COVID-19
por: Ferrara, Francesco, et al.
Publicado: (2020)

Remdesivir: Bradycardia: case report
Publicado: (2022)

REMDESIVIR CAUSING PROFOUND BRADYCARDIA
por: Sneij, Eliea, et al.
Publicado: (2021)

Remdesivir: Bradycardia: case report
Publicado: (2022)

Remdesivir-associated bradycardia in COVID-19: a rapid review protocol
por: Tian, Elli, et al.
Publicado: (2023)

Remdesivir-induced symptomatic bradycardia in the treatment of COVID-19 disease
por: Jacinto, Jomel Patrick, et al.
Publicado: (2021)

Bradycardia Related to Remdesivir During COVID-19: Persistent or Permanent?
por: Maheshwari, Mani, et al.
Publicado: (2021)

REMDESIVIR THERAPY AND ITS ASSOCIATION WITH SINUS BRADYCARDIA
por: ARSALAN ZAIDI, SYED, et al.
Publicado: (2021)

SYSTEMATIC REVIEW AND META-ANALYSIS OF REMDESIVIR AND BRADYCARDIA IN PATIENTS WITH COVID-19
por: Jipescu, Daniel, et al.
Publicado: (2022)

Remdesivir: Sinus bradycardia: case report
Publicado: (2021)

Remdesivir: Sinus bradycardia: case report
Publicado: (2022)

Remdesivir: Sinus bradycardia: case report
Publicado: (2022)

Remdesivir: Sinus bradycardia: case report
Publicado: (2021)

Remdesivir: Profound bradycardia: case report
Publicado: (2021)

Remdesivir associated sinus bradycardia in patients with COVID-19: A prospective longitudinal study
por: Hajimoradi, Maryam, et al.
Publicado: (2023)

REMDESIVIR ASSOCIATED BRADYCARDIA AND OUTCOMES IN COVID-19 PATIENTS: A MULTICENTER RETROSPECTIVE STUDY
por: Umeh, Chukwuemeka, et al.
Publicado: (2023)

Liver injury in remdesivir-treated COVID-19 patients
por: Zampino, Rosa, et al.
Publicado: (2020)

Remdesivir versus ritonavir/lopinavir in COVID-19 patients
por: Vitiello, Antonio, et al.
Publicado: (2020)

Treatment of patients with COVID-19 on hemodialysis: Efficacy of remdesivir
por: Nakaya, Aya, et al.
Publicado: (2022)

Treatment of patients with COVID-19 on hemodialysis: Efficacy of remdesivir
por: Nakaya, Aya, et al.
Publicado: (2023)

Pulmonary administration of remdesivir in the treatment of COVID-19
por: Rasmussen, Henrik Berg, et al.
Publicado: (2020)

Remdesivir for COVID-19: Why Not Dose Higher?
por: Yan, Victoria C., et al.
Publicado: (2021)

Remdesivir for the treatment of COVID-19: author's response
por: Lee, Todd C., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_e6j1dsgs4tp98vuvg6346o1u6e